Y-Intercept (HK)’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
+4,074
New +$1.07M 0.02% 994
2026
Q1
Sell
-22,506
Closed -$5.65M 1844
2025
Q4
$5.65M Buy
+22,506
New +$5.98M 0.13% 193
2025
Q2
Sell
-3,021
Closed -$703K 1855
2025
Q1
$703K Buy
+3,021
New +$733K 0.05% 551
2024
Q4
Sell
-4,711
Closed -$1.05M 1448
2024
Q3
$1.05M Buy
+4,711
New +$1.04M 0.06% 431
2024
Q2
Sell
-1,688
Closed -$369K 1674
2024
Q1
$369K Sell
1,688
-3,562
-68% -$785K 0.03% 862
2023
Q4
$1.19M Buy
+5,250
New +$1.1M 0.11% 260
2022
Q4
Sell
-23,145
Closed -$4.07M 1193
2022
Q3
$4.07M Buy
+23,145
New +$4.74M 0.41% 31
2021
Q4
Sell
-2,513
Closed -$608K 743
2021
Q3
$608K Buy
+2,513
New +$633K 0.11% 287

Other funds holding LH

Y-Intercept (HK)'s LH Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Labcorp (LH) in Q2 2026: 4,074 shares worth $1.14M. The stake represents 0.02% of the portfolio and ranks #994 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in LH as recently as Q4 2025.

Y-Intercept (HK) first reported a position in LH in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.65M in Q4 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Y-Intercept (HK) held 4,074 shares of Labcorp worth $1.14M as of Q2 2026.
  • Labcorp was a new Y-Intercept (HK) position in Q2 2026.
  • Labcorp made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #994 holding.
  • Y-Intercept (HK) first reported a position in Labcorp in Q3 2021 and has held it in 8 quarters since.
  • Y-Intercept (HK)'s Labcorp position peaked at $5.65M in Q4 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.